---
id: 134
title: Plasmodium Species (Malaria) Diagnosis and Complications
category: organisms
subcategory: parasites
tags: [malaria, Plasmodium, thick-smear, thin-smear, severe-malaria, cerebral-malaria]
difficulty: medium
---

## Question

How is malaria diagnosed and what defines severe malaria? Use the **"Thick Smear (Screening) + Thin Smear (Species/Parasitemia)"** framework.

## Answer

### **Malaria Diagnosis:**

**Microscopy (Gold Standard):**

| Test | Purpose | Details |
|------|---------|---------|
| **Thick smear** | **Screening** (detect parasites) | **More sensitive** (10-20× more blood), lysed RBCs concentrate parasites |
| **Thin smear** | **Species identification** + **quantify parasitemia** | Morphology preserved, calculate % infected RBCs |

**Rapid Diagnostic Tests (RDTs):**
- **Detects:** Plasmodium antigens (HRP-2 for *P. falciparum*, pLDH for other species)
- **Sensitivity:** 95% (*P. falciparum*), lower for other species
- **Advantages:** Fast (15-20 min), no microscopy expertise needed
- **Limitations:** Cannot quantify parasitemia, HRP-2 persists weeks after treatment

**PCR:**
- **Most sensitive** (detects low-level parasitemia)
- **Not widely available**, slow turnaround
- **Use:** Research, confirmation, mixed infections

### **Severe Malaria (*P. falciparum*):**

**WHO Criteria (ANY of the following):**

**Clinical:**
- **Impaired consciousness/coma** (cerebral malaria, GCS <11)
- **Prostration** (unable to sit/stand without assistance)
- **Multiple seizures** (>2 in 24h)
- **Acute respiratory distress** (pulmonary edema)
- **Shock** (systolic BP <80 mmHg)
- **Jaundice** (bilirubin >3 mg/dL)
- **Abnormal bleeding**

**Laboratory:**
- **Severe anemia** (Hgb <7 g/dL OR Hct <20%)
- **Hypoglycemia** (glucose <40 mg/dL)
- **Metabolic acidosis** (pH <7.35 OR bicarbonate <15 mmol/L)
- **Acute kidney injury** (Cr >3 mg/dL)
- **Hyperlactatemia** (lactate >5 mmol/L)
- **Hyperparasitemia** (>5% infected RBCs OR >250,000/μL)
- **Hemoglobinuria** ("blackwater fever")

### **Cerebral Malaria:**

**Definition:**
- ***P. falciparum*** + **unrousable coma** (GCS ≤11) + **no other cause** (exclude hypoglycemia, bacterial meningitis, postictal)

**Pathophysiology:**
- **Sequestration:** Infected RBCs adhere to cerebral vascular endothelium (via PfEMP1)
- **Microvascular obstruction** → cerebral ischemia

**Management:**
- **IV artesunate** (see treatment card)
- **Supportive care:** Airway protection, seizure control, avoid fluid overload
- **Avoid steroids** (worsen outcomes)
- **Monitor glucose** (hypoglycemia common)

**Prognosis:**
- **Mortality:** 15-20% even with treatment
- **Neurologic sequelae:** 10-15% survivors (especially children) - seizures, cognitive impairment, behavioral changes

## Key Points

### **Parasitemia Calculation:**
- **Method:** Count infected RBCs per 1000 RBCs on thin smear
- **Example:** 50 infected RBCs per 1000 = 5% parasitemia
- **Severe:** >5% (or >250,000 parasites/μL)

### **Species Differences:**

| Species | Severity | Unique Features |
|---------|----------|----------------|
| ***P. falciparum*** | **Most severe** | **Cerebral malaria**, high parasitemia, **cytoadherence** (sequestration), **no relapses** (no hypnozoites) |
| ***P. vivax*** | Mild-moderate | **Relapses** (hypnozoites in liver), Duffy-negative resistance (West Africa), severe disease increasingly recognized |
| ***P. ovale*** | Mild | **Relapses** (hypnozoites), rare |
| ***P. malariae*** | Mild | Chronic low-level parasitemia, **nephrotic syndrome** (immune complex GN) |
| ***P. knowlesi*** | **Can be severe** | **Zoonotic** (monkeys), rapid replication (24h cycle), high parasitemia |

### **"Blackwater Fever":**
- **Massive intravascular hemolysis** → hemoglobinuria (dark urine)
- **Associated with:** *P. falciparum*, G6PD deficiency, quinine use (historically)
- **Complications:** AKI, anemia, shock

### **Malaria in Pregnancy:**
- **Increased risk:** Severe disease, maternal mortality, fetal loss, low birth weight
- ***P. falciparum*** sequesters in placenta
- **Treatment:** Artemisinin combinations (2nd/3rd trimester), quinine + clindamycin (1st trimester)
- **Prevention:** IPTp (intermittent preventive therapy with sulfadoxine-pyrimethamine) in endemic areas

### **Clinical Pearls:**
- **Thick smear:** Screening (detect parasites)
- **Thin smear:** Species ID + quantify parasitemia
- **Severe malaria:** Impaired consciousness, seizures, parasitemia >5%, severe anemia, AKI, acidosis
- **Cerebral malaria:** Unrousable coma (GCS ≤11) + *P. falciparum*
- **IV artesunate** for severe malaria (see treatment card)
- ***P. vivax/ovale*:** Relapses (need primaquine for hypnozoites)
- **Check G6PD** before primaquine (hemolysis risk)

## Sources

- [WHO: Malaria Guidelines 2024]
- [CDC: Malaria Diagnosis and Treatment 2024]

## Media

N/A
